Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
Twist Bioscience Corp (TWST)
|
|
| Common Size Income Statement |
|
|
|
|
Annual | Quarterly | TTM |
|
| In millions, except per share items | Sep-30-22 | Sep-30-21 | Sep-30-20 | Sep-30-19 | Jun-30-19 | Sep-30-18 | Jun-30-18 | Sep-30-17 |
| | 10-K | 10-K | 10-K | 10-K | 8-K | 10-K | 8-K | 10-K |
| Revenues | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% |
| Cost of goods sold | 58.6% | 60.9% | 68.2% | 87.2% | 87.2% | 126.6% | 126.6% | 223.1% |
| Gross profit | 41.4% | 39.1% | 31.8% | 12.8% | 12.8% | -26.6% | -26.6% | -123.1% |
| Selling, general and administrative | 104.6% | 102.7% | 114.6% | 147.3% | 147.3% | 170.9% | 170.9% | 242.0% |
| Research and development | 59.1% | 52.2% | 47.7% | 65.6% | 65.6% | 80.0% | 80.0% | 178.0% |
| EBITDA | -108.1% | -108.0% | -123.1% | -188.9% | -200.1% | -255.0% | -277.5% | -496.5% |
| Depreciation | 8.1% | 7.4% | 7.4% | 11.2% | | 22.5% | | 46.6% |
| EBIT | -116.2% | -115.4% | -130.5% | -200.1% | -200.1% | -277.5% | -277.5% | -543.2% |
| Pre-tax income | -112.1% | -116.4% | -154.9% | -197.4% | -198.5% | -279.2% | -281.1% | -548.2% |
| Income taxes | -5.1% | -1.5% | 0.4% | 0.5% | -0.5% | 1.0% | -1.0% | 2.6% |
| Net income | -107.0% | -114.9% | -155.3% | -198.0% | -198.0% | -280.2% | -280.2% | -550.8% |
|